Masis Babajanian, MD
Cardiovascular Disease (Cardiology) · Santa Rosa
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 29 years
- Stanford University School of Medicine, 1997
On the public record
- Owns Advanced Surgery Institute, LLC: Accreditation Lapsed
Offices
1 location · Providence Medical Foundation · 1,461 clinicians in this group
Looking this up.
Hospitals listed: Adventist Health Mendocino Coast · Adventist Health Ukiah Valley · Healdsburg Hospital · Providence Santa Rosa Memorial Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Babajanian’s office at (714) 449-4842 to ask if they take your plan before you enroll.
California Medical Board record
Licence A83907 · Current
Licensed to practise in California · since 2003 · expires 2026-10-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Advanced Surgery Institute, LLCSanta Rosa, CA2.97% owner since 2008 · accredited by IMQAccreditation Lapsed1 inspection · last 2010-04-15
- Advanced Surgery Institute, LLCAmbulatory Surgery Center · Santa Rosa, CAOwner · accredited by JCAccreditation Renewed1 inspection, 1 with deficiencies · last 2012-12-07: Requirements Met
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Mendocino CoastFort Bragg, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 5 of 5 · 80% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Adventist Health Ukiah ValleyUkiah, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.9 (5.8 to 10.5) · 253 cases, Jan 2024 – Dec 2024
- Healdsburg HospitalHealdsburg, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Providence, which runs 54 hospitals in 7 states77% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Mendocino Coast
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 9 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 103 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 268 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 78 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -24.2 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.7 · 102 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.7 (5.2 to 11.1) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.3 to 14.6) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.8 to 17.4) · 526 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 48 cases | No different | Jan 2024 – Dec 2024 |
What patients said (119 patients answered, 22% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 86% |
| Doctors "always" communicated well | 89% |
| Staff "always" explained | 72% |
| Yes, staff "did" give patients this information | 94% |
| Yes, staff "did" give patients information about help after discharge | 94% |
| Doctors "always" explained things so they could understand | 85% |
| Doctors "always" listened carefully | 87% |
| Doctors "always" treated them with courtesy and respect | 96% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| Staff "always" explained new medications | 87% |
| Nurses "always" explained things so they could understand | 82% |
| Nurses "always" listened carefully | 84% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Adventist Health Ukiah Valley
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (5.8 to 10.5) · 253 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 319 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.51 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 647 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,093 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.51) · 2,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.23 to 7.05) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.79 to 4.11) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.32 (2.24 to 10.4) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,614 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.396 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 114 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.9 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (8 to 13.6) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.4) · 1,320 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 361 cases | No different | Jan 2024 – Dec 2024 |
What patients said (341 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Healdsburg Hospital
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 2 the same, 1 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 16.5 · 45 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 109 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.8 · 47 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 31 cases | None | Jul 2023 – Jun 2025 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 94% |
| Yes, staff "did" give patients information about help after discharge | 96% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 84% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 95% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$347,690
Medicare paid this office $347,690 for 2,246 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 622 | $93,678 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 240 | $40,468 | $159 |
| Telephone medical discussion with physician, 21-30 minutes | 199 | $23,566 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 102 | $21,456 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 339 | $18,671 | $54 |
See all 39 services
| Return visit (30+ min) | 622 | $93,678 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 240 | $40,468 | $159 |
| Telephone medical discussion with physician, 21-30 minutes | 199 | $23,566 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 102 | $21,456 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 339 | $18,671 | $54 |
| Ultrasound of both sides of head and neck blood flow | 95 | $14,417 | $150 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,212 | $10,122 | $6 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 17 | $10,110 | $87 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 133 | $9,164 | $22 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 57 | $9,129 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $7,232 | $105 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 114 | $6,815 | $60 |
| Programming of dual lead pacemaker system | 72 | $6,786 | $59 |
| Removal and replacement of dual lead permanent pacemaker | 24 | $6,622 | $276 |
| Short return visit (20+ min) | 79 | $5,997 | $70 |
| Critical care, first 30-74 minutes | 19 | $5,956 | $170 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $5,244 | $142 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $4,859 | $374 |
| Long return visit (40+ min) | 23 | $3,528 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $3,278 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 269 | $3,202 | $11 |
| Ultrasound of heart with probe in esophagus, with report | 33 | $2,924 | $84 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 36 | $2,833 | $27 |
| New patient visit (45+ min) | 24 | $2,663 | $111 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 95 | $1,598 | $17 |
| Evaluation of implantable heart and blood vessel monitoring system | 25 | $1,550 | $36 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $1,214 | $19 |
| External shock to heart to regulate heart beat | 11 | $1,150 | $88 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 97 | $1,092 | $11 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,074 | $67 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 72 | $996 | $14 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 69 | $687 | $10 |
| Ultrasound of heart, follow-up | 19 | $385 | $20 |
| Heart rhythm recording of continous external ekg over 8-15 days | 34 | $352 | $10 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 20 | $339 | $6 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $217 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $79 | $6 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $69 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $68 | $3 |
Procedures Medicare counted
| Pacemaker insertion or repair | 21 | More than 72% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of pacemaker and upper and lower heart chamber electrode | 29 | 13 | 12 | 11 | – | 13 |
| Removal and replacement of dual lead permanent pacemaker | – | – | 19 | – | 21 | 24 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
2,246 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 21% · Women 48% · Also on Medicaid 24% · Health risk score 1.73. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 45% · Atrial fibrillation 44% · Heart failure 38% · Chronic kidney disease 32% · Diabetes 30% · Depression 25% · COPD 23% · Cancer 18% · Stroke 16% · Dementia 14%.
The office billed $1,520,424, Medicare allowed $478,918 and paid $347,690; for 6,391 services of 79 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,246 | 6,391 | 77 | 1.73 | $1,520,424 | $347,690 |
| 2023 | 2,367 | 6,480 | 77 | 1.66 | $1,432,788 | $355,840 |
| 2022 | 2,292 | 6,336 | 77 | 1.66 | $1,414,929 | $370,026 |
| 2021 | 2,132 | 5,213 | 76 | 1.64 | $1,192,149 | $362,087 |
| 2020 | 2,322 | 8,672 | 76 | 1.59 | $2,422,235 | $733,854 |
| 2019 | 2,111 | 8,848 | 76 | 1.60 | $2,623,211 | $769,945 |
| 2018 | 2,029 | 8,091 | 75 | 1.60 | $2,251,187 | $674,915 |
| 2017 | 2,170 | 8,532 | 76 | 1.68 | $2,419,112 | $711,594 |
| 2016 | 1,995 | 8,633 | 75 | 1.59 | $2,514,141 | $730,837 |
| 2015 | 2,041 | 8,091 | 75 | 1.55 | $2,316,886 | $713,797 |
| 2014 | 2,049 | 7,679 | 75 | 1.52 | $2,117,144 | $652,221 |
| 2013 | 1,962 | 8,506 | 75 | 1.56 | $2,463,709 | $749,322 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 39 services
| Return visit (30+ min) | 614 | $94,202 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 226 | $40,149 | $167 |
| Telephone medical discussion with physician, 21-30 minutes | 174 | $22,566 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 368 | $20,693 | $55 |
| Ultrasound of both sides of head and neck blood flow | 104 | $16,502 | $157 |
| Long return visit (40+ min) | 96 | $16,007 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $14,670 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,253 | $9,468 | $6 |
| Short return visit (20+ min) | 106 | $9,044 | $75 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 118 | $8,687 | $23 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $8,508 | $144 |
| Critical care, first 30-74 minutes | 22 | $8,216 | $171 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 139 | $7,970 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 71 | $7,878 | $106 |
| Programming of dual lead pacemaker system | 67 | $6,669 | $55 |
| Removal and replacement of dual lead permanent pacemaker | 21 | $5,735 | $273 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 51 | $3,388 | $19 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $3,355 | $65 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 20 | $2,924 | $19 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 30 | $2,917 | $27 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 206 | $2,549 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 140 | $2,208 | $16 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $1,941 | $88 |
| New patient visit (45+ min) | 14 | $1,933 | $138 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 27 | $1,706 | $18 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 12 | $1,669 | $139 |
| Evaluation of implantable heart and blood vessel monitoring system | 27 | $1,659 | $31 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,574 | $75 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 139 | $1,498 | $11 |
| Programming of dual lead implantable defibrillator system | 11 | $1,249 | $73 |
| Programming of single lead pacemaker system | 13 | $1,239 | $48 |
| Anticoagulant management of patient taking warfarin | 15 | $1,209 | $9 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $1,098 | $69 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 51 | $523 | $10 |
| Ultrasound of heart, follow-up | 18 | $393 | $21 |
| Heart rhythm recording of continous external ekg over 8-15 days | 34 | $369 | $11 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 17 | $309 | $7 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 17 | $100 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $67 | $3 |
2022: 42 services
| Return visit (30+ min) | 561 | $79,645 | $103 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 274 | $52,196 | $174 |
| Long return visit (40+ min) | 226 | $44,952 | $147 |
| Telephone medical discussion with physician, 21-30 minutes | 234 | $25,344 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 265 | $15,819 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $14,203 | $85 |
| Ultrasound of both sides of head and neck blood flow | 83 | $13,036 | $150 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 138 | $9,489 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,215 | $9,388 | $6 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,973 | $166 |
| Programming of dual lead pacemaker system | 69 | $6,586 | $58 |
| Short return visit (20+ min) | 82 | $6,203 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 54 | $6,105 | $113 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 93 | $6,050 | $65 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 37 | $5,849 | $22 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,763 | $433 |
| Ultrasound of heart with probe in esophagus, with report | 38 | $3,981 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 301 | $3,802 | $12 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 61 | $3,730 | $20 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 43 | $3,478 | $28 |
| Ultrasound of leg arteries or artery grafts | 14 | $3,152 | $225 |
| Programming of multiple lead implantable defibrillator system | 19 | $2,546 | $91 |
| Evaluation of implantable heart and blood vessel monitoring system | 38 | $2,452 | $40 |
| New patient visit (60+ min) | 15 | $2,329 | $155 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 15 | $2,165 | $144 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $2,112 | $19 |
| Programming of dual lead implantable defibrillator system | 11 | $1,919 | $77 |
| Ultrasound of heart | 16 | $1,884 | $118 |
| New patient visit (45+ min) | 21 | $1,848 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,494 | $60 |
| Programming of single lead pacemaker system | 14 | $1,306 | $54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 67 | $1,206 | $18 |
| Anticoagulant management of patient taking warfarin | 20 | $964 | $10 |
| Programming of multiple lead pacemaker system | 13 | $857 | $57 |
| Ultrasound study of arm and leg arteries | 14 | $844 | $60 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 63 | $770 | $12 |
| Heart rhythm recording of continous external ekg over 8-15 days | 26 | $319 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 29 | $300 | $10 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 17 | $221 | $6 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $181 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 15 | $104 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $39 | $3 |
2021: 52 services
| Return visit (30+ min) | 714 | $90,070 | $98 |
| Long return visit (40+ min) | 222 | $43,489 | $151 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 232 | $41,926 | $167 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 220 | $13,261 | $59 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 29 | $12,379 | $427 |
| Telephone medical discussion with physician, 21-30 minutes | 111 | $11,857 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $9,742 | $87 |
| Ultrasound of both sides of head and neck blood flow | 67 | $8,417 | $126 |
| Short return visit (20+ min) | 110 | $7,426 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $6,939 | $161 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 141 | $6,271 | $24 |
| Programming of dual lead pacemaker system | 74 | $6,118 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 781 | $6,116 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $5,899 | $61 |
| Removal and replacement of dual lead permanent pacemaker | 19 | $5,734 | $302 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 29 | $5,476 | $94 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $5,274 | $439 |
| New patient visit (45+ min) | 45 | $5,267 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,594 | $115 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 351 | $4,330 | $12 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 62 | $4,065 | $66 |
| Injection, regadenoson, 0.1 mg | 18 | $3,097 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $3,053 | $235 |
| New patient visit (60+ min) | 16 | $2,747 | $172 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 31 | $2,585 | $22 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,459 | $85 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 43 | $2,366 | $30 |
| Ultrasound of leg arteries or artery grafts | 12 | $2,344 | $195 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 18 | $2,341 | $130 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $2,319 | $93 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $2,031 | $169 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 33 | $1,691 | $51 |
| Evaluation of implantable heart and blood vessel monitoring system | 31 | $1,338 | $38 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,313 | $88 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 53 | $1,242 | $22 |
| Programming of single lead pacemaker system | 13 | $1,221 | $56 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 47 | $1,162 | $22 |
| Ultrasound of heart, follow-up | 12 | $1,124 | $86 |
| External shock to heart to regulate heart beat | 11 | $989 | $90 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $977 | $61 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 11 | $926 | $84 |
| Ultrasound study of arm and leg arteries | 19 | $841 | $44 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $698 | $47 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 15 | $654 | $44 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 28 | $604 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 30 | $560 | $19 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 16 | $533 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $455 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 30 | $375 | $13 |
| Heart rhythm recording of continous external ekg over 8-15 days | 27 | $329 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $217 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $48 | $3 |
2020: 54 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 344 | $147,087 | $425 |
| Return visit (30+ min) | 884 | $110,228 | $84 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 346 | $67,235 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 340 | $62,908 | $165 |
| Long return visit (40+ min) | 328 | $62,484 | $117 |
| Injection, regadenoson, 0.1 mg | 166 | $31,210 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $22,541 | $88 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 346 | $18,262 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $16,467 | $170 |
| Ultrasound of leg arteries or artery grafts | 61 | $13,597 | $216 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 91 | $12,737 | $138 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 151 | $9,503 | $63 |
| Short return visit (20+ min) | 135 | $8,902 | $58 |
| New patient visit (45+ min) | 75 | $8,829 | $118 |
| Anticoagulant management of patient taking warfarin | 52 | $7,540 | $10 |
| Critical care, first 30-74 minutes | 19 | $6,560 | $187 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 437 | $6,134 | $13 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,750 | $442 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 27 | $5,529 | $197 |
| Ultrasound study of arm and leg arteries | 92 | $5,376 | $57 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 28 | $4,614 | $165 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 102 | $4,439 | $23 |
| Programming of dual lead pacemaker system | 55 | $4,391 | $59 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 120 | $4,372 | $20 |
| Ultrasound of both sides of head and neck blood flow | 24 | $4,113 | $171 |
| New patient visit (60+ min) | 25 | $3,614 | $145 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 34 | $3,524 | $101 |
| Ultrasound scan of abdominal aorta | 27 | $3,463 | $128 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 14 | $3,356 | $240 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $3,312 | $301 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,991 | $249 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 356 | $2,680 | $7 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,276 | $95 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 26 | $1,862 | $22 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,620 | $90 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 29 | $1,583 | $26 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 16 | $1,380 | $86 |
| New patient visit (30+ min) | 15 | $1,217 | $81 |
| Ultrasound of heart, follow-up | 12 | $1,177 | $91 |
| Evaluation of implantable heart and blood vessel monitoring system | 29 | $1,169 | $30 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 17 | $1,052 | $20 |
| Programming of dual lead implantable defibrillator system | 11 | $998 | $67 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 42 | $972 | $22 |
| Programming of single lead pacemaker system | 12 | $900 | $53 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 25 | $860 | $32 |
| External ekg recording for more than 48 hours up to 21 days | 32 | $829 | $24 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $818 | $68 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $603 | $40 |
| Test for exercise-induced lung stress | 16 | $588 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 51 | $555 | $10 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $508 | $16 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $334 | $16 |
| Injection, aminophyllin, up to 250 mg | 15 | $59 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $58 | $3 |
2019: 55 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 376 | $159,647 | $423 |
| Return visit (30+ min) | 729 | $96,358 | $83 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 377 | $71,723 | $95 |
| Long return visit (40+ min) | 320 | $68,870 | $116 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 315 | $60,863 | $162 |
| Injection, regadenoson, 0.1 mg | 214 | $38,425 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 132 | $28,582 | $85 |
| Ultrasound of leg arteries or artery grafts | 89 | $19,957 | $222 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 381 | $19,803 | $52 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 120 | $18,632 | $144 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 108 | $17,798 | $165 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 29 | $12,371 | $427 |
| New patient visit (45+ min) | 95 | $11,812 | $124 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 171 | $10,389 | $60 |
| Critical care, first 30-74 minutes | 22 | $8,135 | $181 |
| Ultrasound study of arm and leg arteries | 117 | $7,017 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 453 | $6,976 | $13 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 36 | $6,729 | $187 |
| Ultrasound scan of abdominal aorta | 48 | $5,993 | $125 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 50 | $5,231 | $103 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 84 | $4,914 | $34 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $4,586 | $306 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 104 | $4,484 | $22 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 17 | $4,204 | $234 |
| Ultrasound of heart with probe in esophagus, with report | 43 | $4,093 | $91 |
| Anticoagulant management of patient taking warfarin | 30 | $3,857 | $10 |
| Short return visit (20+ min) | 57 | $3,630 | $55 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,621 | $241 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 75 | $3,467 | $24 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 20 | $3,050 | $152 |
| New patient visit (60+ min) | 17 | $2,871 | $169 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 33 | $2,308 | $46 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 31 | $2,215 | $36 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 47 | $2,106 | $17 |
| Evaluation of implantable heart and blood vessel monitoring system | 43 | $1,974 | $29 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 40 | $1,818 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 192 | $1,652 | $7 |
| Ultrasound of one leg arteries or artery grafts | 12 | $1,414 | $109 |
| External shock to heart to regulate heart beat | 14 | $1,284 | $92 |
| New patient visit (30+ min) | 16 | $1,165 | $73 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 15 | $1,081 | $20 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 48 | $1,059 | $21 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 15 | $1,051 | $66 |
| Ultrasound of heart, follow-up | 13 | $1,008 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $776 | $60 |
| Test for exercise-induced lung stress | 14 | $747 | $28 |
| External ekg recording for more than 48 hours up to 21 days | 31 | $741 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 69 | $737 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 37 | $582 | $15 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $549 | $42 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 15 | $501 | $10 |
| Blood test, clotting time | 20 | $415 | $4 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $281 | $22 |
| Injection, aminophyllin, up to 250 mg | 28 | $110 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 37 | $101 | $3 |
2018: 60 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 322 | $137,632 | $426 |
| Return visit (30+ min) | 670 | $96,095 | $81 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 321 | $61,122 | $95 |
| Long return visit (40+ min) | 225 | $50,755 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 243 | $49,878 | $169 |
| Injection, regadenoson, 0.1 mg | 191 | $33,304 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 128 | $26,164 | $85 |
| Ultrasound of leg arteries or artery grafts | 103 | $22,996 | $223 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 323 | $16,673 | $52 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 111 | $15,720 | $139 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $14,411 | $164 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 136 | $8,197 | $60 |
| New patient visit (45+ min) | 69 | $8,186 | $119 |
| Ultrasound study of arm and leg arteries | 124 | $7,506 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 430 | $7,075 | $13 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 37 | $7,034 | $185 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $6,556 | $410 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 25 | $6,089 | $244 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 48 | $4,794 | $94 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 101 | $4,392 | $23 |
| Ultrasound scan of abdominal aorta | 42 | $4,316 | $103 |
| Programming of dual lead pacemaker system | 66 | $4,283 | $44 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 24 | $4,128 | $172 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,954 | $304 |
| Ultrasound of heart with probe in esophagus, with report | 40 | $3,707 | $90 |
| Critical care, first 30-74 minutes | 12 | $3,610 | $180 |
| Ultrasound of one leg arteries or artery grafts | 28 | $3,405 | $113 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 71 | $3,180 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 353 | $3,037 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,792 | $215 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 30 | $2,778 | $46 |
| Short return visit (20+ min) | 45 | $2,554 | $54 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 41 | $2,492 | $15 |
| New patient visit (60+ min) | 14 | $2,249 | $161 |
| New patient visit (30+ min) | 24 | $1,886 | $79 |
| Evaluation of implantable heart and blood vessel monitoring system | 39 | $1,884 | $27 |
| Programming of multiple lead implantable defibrillator system | 16 | $1,784 | $66 |
| Programming of dual lead implantable defibrillator system | 20 | $1,781 | $61 |
| Complete ultrasound study of arm and leg arteries | 16 | $1,687 | $105 |
| Ultrasound of heart, follow-up | 17 | $1,530 | $81 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 23 | $1,505 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,451 | $112 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 36 | $1,415 | $21 |
| External shock to heart to regulate heart beat | 15 | $1,370 | $91 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 12 | $1,209 | $101 |
| Programming of single lead pacemaker system | 23 | $1,179 | $39 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 35 | $1,173 | $32 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 46 | $1,000 | $21 |
| External ekg recording for more than 48 hours up to 21 days | 32 | $748 | $23 |
| Blood test, clotting time | 24 | $732 | $5 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $640 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 56 | $592 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 37 | $563 | $15 |
| Test for exercise-induced lung stress | 15 | $546 | $27 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 12 | $531 | $44 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 18 | $491 | $7 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $222 | $19 |
| Electrocardiogram (ecg) 2-day continuous | 11 | $222 | $20 |
| Injection, aminophyllin, up to 250 mg | 29 | $109 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 38 | $101 | $3 |
2017: 54 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 402 | $167,425 | $410 |
| Return visit (30+ min) | 604 | $76,185 | $80 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 401 | $75,823 | $94 |
| Long return visit (40+ min) | 284 | $57,034 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 232 | $48,324 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 149 | $40,431 | $85 |
| Injection, regadenoson, 0.1 mg | 221 | $36,900 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 402 | $21,733 | $54 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 100 | $15,265 | $140 |
| Ultrasound of leg arteries or artery grafts | 67 | $14,783 | $221 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $12,428 | $164 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 153 | $8,394 | $52 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 34 | $7,804 | $223 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,601 | $422 |
| New patient visit (45+ min) | 55 | $6,994 | $127 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 456 | $6,966 | $13 |
| Ultrasound study of arm and leg arteries | 93 | $5,796 | $59 |
| Programming of dual lead pacemaker system | 68 | $4,735 | $45 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 20 | $4,663 | $233 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $4,564 | $304 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 42 | $4,126 | $96 |
| Ultrasound of heart with probe in esophagus, with report | 44 | $4,048 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 477 | $3,887 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 96 | $3,755 | $22 |
| Ultrasound scan of abdominal aorta | 37 | $3,633 | $98 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $3,274 | $234 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 70 | $3,046 | $26 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 26 | $3,043 | $55 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 17 | $2,939 | $163 |
| New patient visit (60+ min) | 16 | $2,561 | $160 |
| Ultrasound of both sides of head and neck blood flow | 14 | $2,358 | $168 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 45 | $2,326 | $14 |
| Short return visit (20+ min) | 38 | $2,236 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $2,176 | $59 |
| Programming of dual lead implantable defibrillator system | 20 | $2,127 | $64 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 30 | $1,948 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,832 | $108 |
| Evaluation of implantable heart and blood vessel monitoring system | 30 | $1,288 | $23 |
| Programming of single lead pacemaker system | 20 | $1,287 | $38 |
| External shock to heart to regulate heart beat | 14 | $1,271 | $91 |
| Pulmonary exercise testing | 13 | $1,164 | $47 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 29 | $1,147 | $22 |
| Ultrasound of one leg arteries or artery grafts | 11 | $1,119 | $102 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 12 | $1,054 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 42 | $922 | $20 |
| Blood test, clotting time | 38 | $855 | $5 |
| External ekg recording for more than 48 hours up to 21 days | 35 | $848 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 74 | $801 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 37 | $574 | $15 |
| Injection, aminophyllin, up to 250 mg | 133 | $507 | None |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 19 | $473 | $6 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $322 | $21 |
| Electrocardiogram (ecg) 2-day continuous | 12 | $271 | $19 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 37 | $100 | $3 |
2016: 54 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 427 | $176,822 | $411 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 429 | $81,825 | $95 |
| Return visit (30+ min) | 570 | $73,141 | $79 |
| Long return visit (40+ min) | 255 | $49,010 | $113 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 221 | $44,733 | $178 |
| Injection, regadenoson, 0.1 mg | 234 | $38,751 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 155 | $35,753 | $84 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 431 | $23,421 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 123 | $20,720 | $162 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 116 | $17,330 | $142 |
| Ultrasound of leg arteries or artery grafts | 99 | $16,172 | $159 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 25 | $10,797 | $432 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 185 | $9,791 | $52 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 475 | $8,019 | $13 |
| Ultrasound study of arm and leg arteries | 132 | $7,893 | $56 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 49 | $7,817 | $153 |
| New patient visit (45+ min) | 58 | $7,024 | $121 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 31 | $6,879 | $222 |
| Programming of dual lead pacemaker system | 76 | $4,952 | $42 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 49 | $4,723 | $94 |
| Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening | 36 | $4,405 | $122 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $4,102 | $316 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 28 | $4,013 | $54 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 60 | $4,013 | $65 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 40 | $3,968 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 85 | $3,875 | $21 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,517 | $234 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,322 | $111 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 58 | $2,836 | $26 |
| Ultrasound of heart with probe in esophagus, with report | 27 | $2,783 | $99 |
| Programming of multiple lead implantable defibrillator system | 17 | $2,374 | $74 |
| Short return visit (20+ min) | 35 | $2,039 | $55 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 12 | $1,992 | $166 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 197 | $1,983 | $7 |
| New patient visit (60+ min) | 11 | $1,853 | $168 |
| New patient visit (30+ min) | 21 | $1,779 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $1,695 | $58 |
| Programming of dual lead implantable defibrillator system | 20 | $1,652 | $57 |
| Blood test, clotting time | 31 | $1,486 | $5 |
| Ultrasound of one leg arteries or artery grafts | 13 | $1,418 | $109 |
| Pulmonary exercise testing | 15 | $1,410 | $44 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 23 | $930 | $21 |
| Programming of single lead pacemaker system | 14 | $861 | $37 |
| Evaluation of implantable heart and blood vessel monitoring system | 24 | $853 | $23 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 35 | $805 | $22 |
| External ekg recording for more than 48 hours up to 21 days | 29 | $680 | $22 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 21 | $526 | $7 |
| Ultrasound of heart blood flow, valves and chambers | 25 | $392 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $333 | $18 |
| Injection, aminophyllin, up to 250 mg | 76 | $298 | None |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $283 | $22 |
| Electrocardiogram (ecg) 2-day continuous | 14 | $278 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $214 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $71 | $3 |
2015: 53 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 326 | $134,777 | $412 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 328 | $86,466 | $132 |
| Return visit (30+ min) | 543 | $75,646 | $82 |
| Long return visit (40+ min) | 294 | $56,175 | $113 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 232 | $47,568 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 166 | $35,669 | $84 |
| Injection, regadenoson, 0.1 mg | 180 | $29,399 | None |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 189 | $27,454 | $138 |
| Ultrasound of leg arteries or artery grafts | 131 | $25,535 | $188 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $21,090 | $165 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 332 | $17,761 | $53 |
| Ultrasound study of arm and leg arteries | 197 | $12,388 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 193 | $10,134 | $52 |
| New patient visit (45+ min) | 64 | $7,819 | $122 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,765 | $431 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 447 | $7,207 | $13 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 28 | $7,073 | $221 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 38 | $6,292 | $153 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 57 | $6,106 | $98 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 91 | $5,911 | $65 |
| Programming of dual lead pacemaker system | 68 | $5,331 | $45 |
| Ultrasound of one leg arteries or artery grafts | 33 | $4,644 | $119 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 37 | $4,424 | $15 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $3,915 | $245 |
| Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening | 31 | $3,783 | $122 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 72 | $3,560 | $20 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 28 | $3,433 | $50 |
| Ultrasound of heart with probe in esophagus, with report | 31 | $3,083 | $99 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 44 | $2,696 | $23 |
| Programming of dual lead implantable defibrillator system | 20 | $2,670 | $65 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 12 | $2,458 | $205 |
| New patient visit (60+ min) | 13 | $2,198 | $169 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 189 | $1,753 | $7 |
| Programming of multiple lead implantable defibrillator system | 14 | $1,740 | $67 |
| Pulmonary exercise testing | 16 | $1,682 | $45 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,667 | $111 |
| Blood test, clotting time | 35 | $1,619 | $5 |
| New patient visit (30+ min) | 18 | $1,396 | $78 |
| Short return visit (20+ min) | 24 | $1,348 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,234 | $59 |
| External shock to heart to regulate heart beat | 12 | $1,210 | $101 |
| Programming of single lead pacemaker system | 18 | $1,144 | $37 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 30 | $693 | $21 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 19 | $628 | $21 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 22 | $616 | $7 |
| External ekg recording for more than 48 hours up to 21 days | 23 | $502 | $20 |
| Electrocardiogram (ecg) 2-day continuous | 16 | $379 | $22 |
| Evaluation of implantable heart and blood vessel monitoring system | 15 | $330 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $317 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $310 | $18 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $287 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $202 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $59 | $3 |
2014: 44 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 296 | $120,006 | $404 |
| Return visit (30+ min) | 632 | $80,578 | $80 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 296 | $77,370 | $130 |
| Long return visit (40+ min) | 266 | $53,032 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 235 | $49,331 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 150 | $31,353 | $84 |
| Injection, regadenoson, 0.1 mg | 179 | $28,857 | None |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 156 | $27,873 | $170 |
| Ultrasound of leg arteries or artery grafts | 110 | $21,486 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $16,159 | $162 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 301 | $16,042 | $53 |
| Ultrasound study of arm and leg arteries | 160 | $9,835 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 164 | $8,657 | $52 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $6,778 | $424 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 29 | $6,537 | $225 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 416 | $6,416 | $13 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 68 | $6,335 | $89 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 41 | $6,094 | $142 |
| New patient visit (45+ min) | 48 | $5,813 | $121 |
| Programming of dual lead pacemaker system | 70 | $5,554 | $44 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 55 | $4,758 | $15 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $4,089 | $315 |
| Ultrasound of one leg arteries or artery grafts | 29 | $3,610 | $109 |
| New patient visit (60+ min) | 21 | $3,319 | $158 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 340 | $3,176 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 45 | $2,971 | $65 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 20 | $2,500 | $53 |
| Pulmonary exercise testing | 15 | $2,357 | $46 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 11 | $2,272 | $207 |
| Short return visit (20+ min) | 38 | $2,117 | $56 |
| Programming of dual lead implantable defibrillator system | 22 | $2,090 | $63 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 50 | $2,005 | $21 |
| Blood test, clotting time | 59 | $1,788 | $5 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $1,626 | $81 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 30 | $1,229 | $25 |
| Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening | 17 | $1,165 | $69 |
| Programming of single lead pacemaker system | 17 | $1,136 | $37 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 23 | $616 | $7 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 25 | $524 | $20 |
| Electrocardiogram (ecg) 2-day continuous | 25 | $522 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 17 | $362 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $252 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $166 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $53 | $3 |
2013: 47 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 425 | $180,225 | $422 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 429 | $112,356 | $131 |
| Return visit (30+ min) | 608 | $77,415 | $79 |
| Long return visit (40+ min) | 287 | $52,479 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 255 | $41,299 | $145 |
| Injection, regadenoson, 0.1 mg | 247 | $41,168 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 168 | $37,824 | $81 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 427 | $23,806 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 112 | $18,022 | $157 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 116 | $17,898 | $152 |
| Ultrasound of leg arteries or artery grafts | 89 | $14,394 | $162 |
| Ultrasound study of arm and leg arteries | 134 | $8,661 | $63 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $7,546 | $397 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 428 | $7,309 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 141 | $7,225 | $50 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 33 | $6,896 | $192 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 67 | $6,370 | $15 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 51 | $5,060 | $94 |
| Programming of dual lead pacemaker system | 68 | $4,940 | $42 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 24 | $4,824 | $201 |
| New patient visit (45+ min) | 36 | $4,643 | $129 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,580 | $229 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 24 | $3,704 | $154 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 52 | $3,293 | $61 |
| Hospital discharge day management, more than 30 minutes | 39 | $3,281 | $84 |
| New patient visit (60+ min) | 19 | $3,025 | $159 |
| Ultrasound of heart with probe in esophagus, with report | 36 | $2,986 | $83 |
| Programming of dual lead implantable defibrillator system | 24 | $2,479 | $58 |
| Ultrasound of one leg arteries or artery grafts | 20 | $2,375 | $103 |
| Blood test, clotting time | 70 | $2,374 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 235 | $2,108 | $7 |
| Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening | 16 | $1,857 | $116 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $1,839 | $47 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 29 | $1,222 | $20 |
| Short return visit (20+ min) | 20 | $1,129 | $56 |
| Programming of single lead pacemaker system | 16 | $912 | $35 |
| Electrocardiogram (ecg) 2-day continuous | 39 | $885 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 40 | $864 | $21 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 21 | $783 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 15 | $525 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 33 | $485 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $326 | $30 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 15 | $295 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $210 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $139 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 33 | $97 | $3 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 12 | $92 | $8 |
Medicaid work
$30,044 in 2024
Medicaid paid $30,044 for 1,359 billed services this clinician did in 2024, up to 131 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,022 | $14,193 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 177 | $12,201 |
| Return visit (30+ min) | 160 | $3,650 |
| 2024 | 1,359 | 3 | 131 | $30,044 |
| 2023 | 1,272 | 4 | 119 | $33,183 |
| 2022 | 944 | 3 | 89 | $27,617 |
| 2021 | 838 | 8 | 66 | $39,495 |
| 2020 | 1,372 | 10 | 43 | $93,820 |
| 2019 | 456 | 8 | 41 | $33,071 |
| 2018 | 149 | 4 | 29 | $7,093 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 874 | $14,370 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 205 | $13,765 |
| Return visit (30+ min) | 170 | $4,275 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $774 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 721 | $12,725 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 136 | $12,134 |
| Return visit (30+ min) | 87 | $2,758 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 181 | $18,822 |
| Return visit (30+ min) | 198 | $6,291 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 389 | $4,808 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 20 | $3,414 |
| Tc99m sestamibi | 13 | $2,814 |
| Injection, regadenoson, 0.1 mg | 12 | $1,732 |
| CARDIOVASCULAR STRESS TEST | 13 | $1,325 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 12 | $288 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 324 | $32,973 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 95 | $16,328 |
| Tc99m sestamibi | 61 | $12,840 |
| Return visit (30+ min) | 325 | $10,387 |
| Long return visit (40+ min) | 153 | $6,772 |
| CARDIOVASCULAR STRESS TEST | 62 | $6,283 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 135 | $4,118 |
| Injection, regadenoson, 0.1 mg | 12 | $1,881 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 176 | $1,305 |
| Short return visit (20+ min) | 29 | $932 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 162 | $17,519 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 25 | $4,109 |
| Tc99m sestamibi | 16 | $3,271 |
| Long return visit (40+ min) | 47 | $2,751 |
| Return visit (30+ min) | 61 | $2,081 |
| CARDIOVASCULAR STRESS TEST | 16 | $1,529 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 103 | $1,014 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 26 | $796 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 32 | $3,819 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 27 | $1,434 |
| Return visit (30+ min) | 14 | $971 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 76 | $868 |
Drugs they prescribed that Part D paid
$3,731,253
Pharmacies billed $3,731,253 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 6,852) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
5,224 generic and 1,628 brand-name prescriptions · $3,731,253 in drug cost · 16 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 667 | $866,362 | $1,299 |
| Adempas | 48 | $645,287 | $13,443 |
| Opsumit | 52 | $628,255 | $12,082 |
| Entresto | 330 | $480,892 | $1,457 |
| Uptravi | 22 | $221,773 | $10,081 |
See all 72 drugs
| Eliquis | 667 | $866,362 | $1,299 |
| Adempas | 48 | $645,287 | $13,443 |
| Opsumit | 52 | $628,255 | $12,082 |
| Entresto | 330 | $480,892 | $1,457 |
| Uptravi | 22 | $221,773 | $10,081 |
| Jardiance | 102 | $134,383 | $1,317 |
| Xarelto | 51 | $72,788 | $1,427 |
| Repatha Sureclick | 64 | $56,266 | $879 |
| Ambrisentan | 12 | $41,244 | $3,437 |
| Tadalafil | 22 | $27,757 | $1,262 |
| Praluent | 23 | $21,608 | $939 |
| Multaq | 11 | $17,808 | $1,619 |
| Farxiga | 15 | $17,352 | $1,157 |
| Livalo | 18 | $13,515 | $751 |
| Ezetimibe | 330 | $11,668 | $35 |
| Rosuvastatin | 537 | $9,578 | $18 |
| Repatha Pushtronex | 13 | $7,902 | $608 |
| Nebivolol | 95 | $7,835 | $82 |
| Metoprolol | 493 | $7,695 | $16 |
| Pitavastatin | 18 | $6,416 | $356 |
| Crestor | 21 | $6,198 | $295 |
| Valsartan | 169 | $5,972 | $35 |
| Dofetilide | 19 | $5,716 | $301 |
| Atorvastatin | 467 | $5,108 | $11 |
| Flecainide Acetate | 89 | $4,794 | $54 |
| Varenicline | 12 | $3,176 | $265 |
| Icosapent Ethyl | 11 | $3,166 | $288 |
| Clopidogrel | 229 | $2,834 | $12 |
| Bisoprolol | 73 | $2,605 | $36 |
| Potassium Chloride | 106 | $2,527 | $24 |
| Diltiazem 24hr Er (Cd) | 81 | $2,431 | $30 |
| Lisinopril | 174 | $2,061 | $12 |
| Amiodarone | 63 | $1,963 | $31 |
| Carvedilol | 180 | $1,937 | $11 |
| Amlodipine Besylate | 251 | $1,919 | $8 |
| Ranolazine Er | 25 | $1,898 | $76 |
| Spironolactone | 173 | $1,824 | $11 |
| Losartan | 142 | $1,757 | $12 |
| Olmesartan Medoxomil | 83 | $1,743 | $21 |
| Furosemide | 201 | $1,529 | $8 |
| Hydralazine | 36 | $1,224 | $34 |
| Isosorbide Mononitrate Er | 53 | $1,102 | $21 |
| Digoxin | 45 | $1,096 | $24 |
| Metoprolol | 124 | $1,051 | $8 |
| Diltiazem 24hr Er | 19 | $683 | $36 |
| Verapamil Er | 26 | $681 | $26 |
| Benazepril | 61 | $658 | $11 |
| Minoxidil | 11 | $648 | $59 |
| Simvastatin | 61 | $645 | $11 |
| Pravastatin | 40 | $628 | $16 |
| Albuterol Sulfate Hfa | 27 | $626 | $23 |
| Nitroglycerin | 42 | $615 | $15 |
| Triamterene-Hydrochlorothiazid | 41 | $594 | $14 |
| Atenolol | 27 | $584 | $22 |
| Fenofibrate | 11 | $572 | $52 |
| Sotalol | 25 | $524 | $21 |
| Hydrochlorothiazide | 74 | $523 | $7 |
| Warfarin | 40 | $492 | $12 |
| Bumetanide | 18 | $463 | $26 |
| Losartan-Hydrochlorothiazide | 30 | $462 | $15 |
| Tamsulosin | 25 | $445 | $18 |
| Omeprazole | 19 | $422 | $22 |
| Montelukast | 22 | $394 | $18 |
| Diltiazem | 17 | $380 | $22 |
| Celecoxib | 13 | $329 | $25 |
| Diltiazem 24hr Er (Xr) | 11 | $293 | $27 |
| Torsemide | 12 | $264 | $22 |
| Valsartan-Hydrochlorothiazide | 20 | $245 | $12 |
| Ramipril | 12 | $164 | $14 |
| Irbesartan | 15 | $157 | $10 |
| Lisinopril-Hydrochlorothiazide | 11 | $78 | $7 |
| Clonidine | 14 | $47 | $3 |
Year by year
| 2024 | 6,852 | 1,000 | 0% (0) | 24% | $3,731,253 |
| 2023 | 6,815 | 1,039 | 0% (0) | 22% | $3,743,557 |
| 2022 | 6,547 | 1,065 | None | 22% | $3,009,683 |
| 2021 | 7,034 | 1,432 | None | 21% | $2,767,522 |
| 2020 | 6,855 | 1,510 | None | 23% | $2,813,171 |
| 2019 | 5,706 | 1,233 | None | 24% | $2,847,167 |
| 2018 | 5,338 | 1,170 | None | None | $2,959,677 |
| 2017 | 4,865 | 1,057 | None | None | $2,338,004 |
| 2016 | 5,016 | 986 | None | 29% | $1,792,750 |
| 2015 | 4,859 | 989 | 0% (11) | 27% | $985,051 |
| 2014 | 5,359 | 937 | 0% (16) | None | $885,145 |
| 2013 | 5,509 | 839 | 0% (16) | 27% | $629,467 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 72 drugs
| Eliquis | 634 | $887,559 | $1,400 |
| Opsumit | 51 | $647,088 | $12,688 |
| Adempas | 32 | $430,499 | $13,453 |
| Uptravi | 18 | $428,457 | $23,803 |
| Entresto | 267 | $408,350 | $1,529 |
| Orenitram Er | 16 | $147,683 | $9,230 |
| Xarelto | 85 | $117,511 | $1,382 |
| Tadalafil | 19 | $66,947 | $3,524 |
| Adcirca | 15 | $66,816 | $4,454 |
| Repatha Sureclick | 58 | $59,337 | $1,023 |
| Jardiance | 35 | $57,067 | $1,630 |
| Livalo | 40 | $34,867 | $872 |
| Farxiga | 24 | $23,651 | $985 |
| Praluent | 29 | $21,552 | $743 |
| Rosuvastatin | 499 | $16,913 | $34 |
| Dofetilide | 41 | $15,499 | $378 |
| Verquvo | 12 | $15,107 | $1,259 |
| Ezetimibe | 288 | $12,388 | $43 |
| Metoprolol | 548 | $12,252 | $22 |
| Atorvastatin | 491 | $10,195 | $21 |
| Diltiazem 24hr Er (Cd) | 109 | $8,656 | $79 |
| Crestor | 24 | $8,244 | $344 |
| Valsartan | 141 | $7,253 | $51 |
| Potassium Chloride | 93 | $6,226 | $67 |
| Nebivolol | 59 | $5,922 | $100 |
| Varenicline | 12 | $5,183 | $432 |
| Flecainide Acetate | 100 | $4,887 | $49 |
| Clopidogrel | 206 | $4,593 | $22 |
| Carvedilol | 222 | $4,130 | $19 |
| Bisoprolol | 65 | $3,947 | $61 |
| Ranolazine Er | 27 | $3,636 | $135 |
| Clonidine | 16 | $3,415 | $213 |
| Lisinopril | 232 | $2,952 | $13 |
| Olmesartan Medoxomil | 72 | $2,937 | $41 |
| Amlodipine Besylate | 221 | $2,500 | $11 |
| Spironolactone | 161 | $2,269 | $14 |
| Metoprolol | 138 | $2,128 | $15 |
| Losartan | 126 | $2,059 | $16 |
| Furosemide | 183 | $1,923 | $11 |
| Digoxin | 49 | $1,726 | $35 |
| Amiodarone | 60 | $1,633 | $27 |
| Hydralazine | 34 | $1,624 | $48 |
| Isosorbide Mononitrate Er | 45 | $1,584 | $35 |
| Benazepril | 81 | $1,457 | $18 |
| Dilt-Xr | 18 | $1,131 | $63 |
| Sotalol | 25 | $1,090 | $44 |
| Bumetanide | 18 | $1,068 | $59 |
| Tamsulosin | 32 | $966 | $30 |
| Diltiazem 24hr Er (Xr) | 18 | $959 | $53 |
| Montelukast | 47 | $927 | $20 |
| Nitroglycerin | 47 | $906 | $19 |
| Warfarin | 58 | $855 | $15 |
| Diltiazem | 19 | $835 | $44 |
| Triamterene-Hydrochlorothiazid | 38 | $814 | $21 |
| Hydrochlorothiazide | 111 | $788 | $7 |
| Albuterol Sulfate Hfa | 26 | $760 | $29 |
| Cartia Xt | 15 | $696 | $46 |
| Torsemide | 14 | $683 | $49 |
| Diltiazem 24hr Er | 15 | $607 | $40 |
| Simvastatin | 50 | $570 | $11 |
| Losartan-Hydrochlorothiazide | 13 | $553 | $43 |
| Atenolol | 32 | $492 | $15 |
| Pravastatin | 28 | $487 | $17 |
| Chlorthalidone | 16 | $475 | $30 |
| Valsartan-Hydrochlorothiazide | 18 | $451 | $25 |
| Omeprazole | 13 | $419 | $32 |
| Verapamil Er | 19 | $384 | $20 |
| Ramipril | 16 | $348 | $22 |
| Levothyroxine | 28 | $333 | $12 |
| Pantoprazole | 11 | $188 | $17 |
| Verapamil | 11 | $74 | $7 |
| Irbesartan | 12 | $73 | $6 |
2022: 70 drugs
| Eliquis | 599 | $770,426 | $1,286 |
| Opsumit | 44 | $527,357 | $11,985 |
| Adempas | 27 | $344,771 | $12,769 |
| Entresto | 230 | $322,367 | $1,402 |
| Orenitram Er | 33 | $276,133 | $8,368 |
| Xarelto | 89 | $119,099 | $1,338 |
| Tadalafil | 34 | $92,610 | $2,724 |
| Repatha Sureclick | 73 | $66,343 | $909 |
| Ambrisentan | 12 | $59,569 | $4,964 |
| Livalo | 46 | $38,972 | $847 |
| Praluent | 50 | $30,621 | $612 |
| Pradaxa | 23 | $28,141 | $1,224 |
| Farxiga | 26 | $25,225 | $970 |
| Repatha Pushtronex | 32 | $21,312 | $666 |
| Rosuvastatin | 474 | $20,899 | $44 |
| Ezetimibe | 245 | $18,271 | $75 |
| Dofetilide | 37 | $15,312 | $414 |
| Metoprolol | 513 | $11,382 | $22 |
| Valsartan | 150 | $8,862 | $59 |
| Atorvastatin | 517 | $8,333 | $16 |
| Varenicline | 20 | $7,653 | $383 |
| Flecainide Acetate | 101 | $7,147 | $71 |
| Diltiazem 24hr Er (Cd) | 107 | $6,979 | $65 |
| Crestor | 15 | $6,154 | $410 |
| Carvedilol | 265 | $6,107 | $23 |
| Potassium Chloride | 95 | $4,390 | $46 |
| Nebivolol | 48 | $4,327 | $90 |
| Ranolazine Er | 27 | $3,806 | $141 |
| Olmesartan Medoxomil | 70 | $2,799 | $40 |
| Lisinopril | 241 | $2,652 | $11 |
| Digoxin | 53 | $2,503 | $47 |
| Clopidogrel | 122 | $2,422 | $20 |
| Propafenone Hcl Er | 13 | $2,294 | $176 |
| Amiodarone | 54 | $2,204 | $41 |
| Bisoprolol | 34 | $2,107 | $62 |
| Amlodipine Besylate | 227 | $2,098 | $9 |
| Losartan | 134 | $2,010 | $15 |
| Bumetanide | 20 | $1,948 | $97 |
| Spironolactone | 142 | $1,585 | $11 |
| Sotalol | 48 | $1,514 | $32 |
| Candesartan Cilexetil | 11 | $1,512 | $137 |
| Isosorbide Mononitrate Er | 38 | $1,511 | $40 |
| Metoprolol | 116 | $1,398 | $12 |
| Furosemide | 156 | $1,378 | $9 |
| Dilt-Xr | 21 | $1,342 | $64 |
| Olmesartan-Hydrochlorothiazide | 14 | $1,320 | $94 |
| Hydralazine | 38 | $1,244 | $33 |
| Warfarin | 63 | $1,208 | $19 |
| Benazepril | 78 | $1,181 | $15 |
| Diltiazem | 20 | $1,002 | $50 |
| Tamsulosin | 25 | $990 | $40 |
| Diltiazem 24hr Er (Xr) | 21 | $929 | $44 |
| Hydrochlorothiazide | 117 | $880 | $8 |
| Montelukast | 57 | $871 | $15 |
| Albuterol Sulfate Hfa | 11 | $867 | $79 |
| Fenofibrate | 13 | $851 | $65 |
| Triamterene-Hydrochlorothiazid | 42 | $835 | $20 |
| Irbesartan | 15 | $831 | $55 |
| Pravastatin | 37 | $831 | $22 |
| Nitroglycerin | 30 | $717 | $24 |
| Simvastatin | 56 | $655 | $12 |
| Diltiazem 24hr Er | 11 | $511 | $46 |
| Levothyroxine | 29 | $465 | $16 |
| Verapamil Er | 15 | $393 | $26 |
| Ramipril | 12 | $358 | $30 |
| Lovastatin | 12 | $342 | $28 |
| Torsemide | 14 | $289 | $21 |
| Omeprazole | 12 | $264 | $22 |
| Atenolol | 23 | $258 | $11 |
| Jantoven | 11 | $47 | $4 |
2021: 69 drugs
| Eliquis | 557 | $676,553 | $1,215 |
| Opsumit | 55 | $600,502 | $10,918 |
| Orenitram Er | 48 | $360,127 | $7,503 |
| Adempas | 21 | $243,273 | $11,584 |
| Entresto | 200 | $242,166 | $1,211 |
| Xarelto | 65 | $78,050 | $1,201 |
| Repatha Sureclick | 79 | $58,426 | $740 |
| Ambrisentan | 24 | $55,312 | $2,305 |
| Pradaxa | 26 | $37,883 | $1,457 |
| Brilinta | 26 | $31,246 | $1,202 |
| Praluent | 54 | $30,160 | $559 |
| Bystolic | 56 | $23,089 | $412 |
| Ezetimibe | 324 | $21,328 | $66 |
| Rosuvastatin | 456 | $21,249 | $47 |
| Livalo | 33 | $19,134 | $580 |
| Tadalafil | 33 | $18,570 | $563 |
| Repatha Pushtronex | 25 | $13,699 | $548 |
| Metoprolol | 529 | $13,642 | $26 |
| Atorvastatin | 678 | $12,291 | $18 |
| Valsartan | 156 | $10,390 | $67 |
| Flecainide Acetate | 99 | $10,129 | $102 |
| Diltiazem 24hr Er (Cd) | 120 | $8,223 | $69 |
| Dofetilide | 24 | $6,936 | $289 |
| Carvedilol | 283 | $5,424 | $19 |
| Olmesartan Medoxomil | 84 | $5,230 | $62 |
| Dilt-Xr | 49 | $4,068 | $83 |
| Ranolazine Er | 13 | $4,012 | $309 |
| Potassium Chloride | 99 | $3,945 | $40 |
| Losartan | 174 | $3,581 | $21 |
| Digoxin | 65 | $3,056 | $47 |
| Warfarin | 124 | $3,038 | $24 |
| Clopidogrel | 155 | $2,998 | $19 |
| Amiodarone | 44 | $2,860 | $65 |
| Amlodipine Besylate | 261 | $2,691 | $10 |
| Spironolactone | 152 | $2,325 | $15 |
| Nebivolol | 12 | $2,312 | $193 |
| Lisinopril | 232 | $2,263 | $10 |
| Olmesartan-Hydrochlorothiazide | 19 | $2,106 | $111 |
| Verapamil Sr | 24 | $1,976 | $82 |
| Furosemide | 178 | $1,685 | $9 |
| Benazepril | 82 | $1,672 | $20 |
| Diltiazem | 23 | $1,638 | $71 |
| Sotalol | 53 | $1,499 | $28 |
| Hydralazine | 47 | $1,391 | $30 |
| Metoprolol | 119 | $1,271 | $11 |
| Albuterol Sulfate Hfa | 18 | $1,197 | $67 |
| Bisoprolol | 28 | $1,135 | $41 |
| Hydrochlorothiazide | 152 | $1,106 | $7 |
| Cartia Xt | 20 | $1,060 | $53 |
| Isosorbide Mononitrate Er | 36 | $1,052 | $29 |
| Celecoxib | 15 | $812 | $54 |
| Candesartan Cilexetil | 13 | $778 | $60 |
| Propranolol | 11 | $738 | $67 |
| Pravastatin | 32 | $700 | $22 |
| Montelukast | 43 | $698 | $16 |
| Diltiazem 24hr Er | 14 | $690 | $49 |
| Chlorthalidone | 15 | $655 | $44 |
| Simvastatin | 52 | $650 | $13 |
| Bumetanide | 12 | $642 | $53 |
| Triamterene-Hydrochlorothiazid | 30 | $583 | $19 |
| Nitroglycerin | 27 | $508 | $19 |
| Irbesartan | 17 | $488 | $29 |
| Enalapril Maleate | 19 | $363 | $19 |
| Tamsulosin | 19 | $331 | $17 |
| Levothyroxine | 16 | $313 | $20 |
| Atenolol | 27 | $308 | $11 |
| Lisinopril-Hydrochlorothiazide | 22 | $304 | $14 |
| Lovastatin | 11 | $279 | $25 |
| Torsemide | 12 | $226 | $19 |
2020: 68 drugs
| Opsumit | 64 | $677,057 | $10,579 |
| Eliquis | 527 | $540,028 | $1,025 |
| Orenitram Er | 55 | $350,749 | $6,377 |
| Entresto | 259 | $261,259 | $1,009 |
| Adempas | 22 | $237,607 | $10,800 |
| Ambrisentan | 33 | $120,906 | $3,664 |
| Tadalafil | 77 | $50,215 | $652 |
| Xarelto | 36 | $39,976 | $1,110 |
| Brilinta | 27 | $28,074 | $1,040 |
| Bystolic | 65 | $27,568 | $424 |
| Repatha Sureclick | 51 | $27,554 | $540 |
| Pradaxa | 22 | $23,790 | $1,081 |
| Rosuvastatin | 379 | $19,792 | $52 |
| Praluent | 19 | $17,436 | $918 |
| Livalo | 30 | $16,709 | $557 |
| Metoprolol | 511 | $15,362 | $30 |
| Corlanor | 15 | $14,129 | $942 |
| Ezetimibe | 185 | $13,173 | $71 |
| Repatha Pushtronex | 26 | $13,083 | $503 |
| Atorvastatin | 633 | $12,781 | $20 |
| Flecainide Acetate | 100 | $11,807 | $118 |
| Ranolazine Er | 34 | $8,832 | $260 |
| Diltiazem 24hr Er (Cd) | 119 | $7,029 | $59 |
| Olmesartan Medoxomil | 110 | $6,944 | $63 |
| Valsartan | 111 | $6,664 | $60 |
| Nexletol | 11 | $5,169 | $470 |
| Potassium Chloride | 106 | $4,256 | $40 |
| Carvedilol | 290 | $3,923 | $14 |
| Losartan | 183 | $3,463 | $19 |
| Warfarin | 126 | $3,314 | $26 |
| Olmesartan-Hydrochlorothiazide | 24 | $3,286 | $137 |
| Amlodipine Besylate | 275 | $2,795 | $10 |
| Digoxin | 52 | $2,711 | $52 |
| Cartia Xt | 44 | $2,548 | $58 |
| Celecoxib | 25 | $2,362 | $94 |
| Albuterol Sulfate Hfa | 38 | $2,277 | $60 |
| Dilt-Xr | 35 | $2,241 | $64 |
| Clopidogrel | 137 | $2,203 | $16 |
| Spironolactone | 174 | $2,025 | $12 |
| Amiodarone | 53 | $2,004 | $38 |
| Bisoprolol | 22 | $1,983 | $90 |
| Diltiazem 24hr Er | 24 | $1,962 | $82 |
| Lisinopril | 194 | $1,767 | $9 |
| Verapamil Sr | 15 | $1,636 | $109 |
| Hydralazine | 43 | $1,533 | $36 |
| Hydrochlorothiazide | 175 | $1,508 | $9 |
| Candesartan Cilexetil | 11 | $1,470 | $134 |
| Furosemide | 173 | $1,457 | $8 |
| Metoprolol | 113 | $1,426 | $13 |
| Benazepril | 94 | $1,172 | $12 |
| Sotalol | 54 | $1,130 | $21 |
| Irbesartan | 15 | $970 | $65 |
| Montelukast | 56 | $907 | $16 |
| Diltiazem | 17 | $862 | $51 |
| Verapamil Er | 22 | $835 | $38 |
| Pravastatin | 35 | $823 | $24 |
| Isosorbide Mononitrate Er | 34 | $784 | $23 |
| Levothyroxine | 28 | $746 | $27 |
| Simvastatin | 60 | $724 | $12 |
| Nitroglycerin | 40 | $711 | $18 |
| Diclofenac | 22 | $658 | $30 |
| Propranolol | 11 | $645 | $59 |
| Atenolol | 25 | $398 | $16 |
| Triamterene-Hydrochlorothiazid | 19 | $330 | $17 |
| Tamsulosin | 12 | $255 | $21 |
| Torsemide | 13 | $250 | $19 |
| Lisinopril-Hydrochlorothiazide | 15 | $211 | $14 |
| Amoxicillin | 11 | $27 | $2 |
2019: 67 drugs
| Opsumit | 89 | $899,009 | $10,101 |
| Eliquis | 351 | $329,471 | $939 |
| Adempas | 25 | $263,247 | $10,530 |
| Uptravi | 12 | $209,346 | $17,446 |
| Orenitram Er | 33 | $187,393 | $5,679 |
| Entresto | 145 | $156,673 | $1,081 |
| Letairis | 13 | $129,464 | $9,959 |
| Tadalafil | 54 | $88,571 | $1,640 |
| Ambrisentan | 15 | $65,728 | $4,382 |
| Xarelto | 64 | $52,998 | $828 |
| Praluent | 49 | $49,024 | $1,000 |
| Repatha Sureclick | 75 | $47,764 | $637 |
| Brilinta | 38 | $38,493 | $1,013 |
| Bystolic | 61 | $24,769 | $406 |
| Rosuvastatin | 339 | $22,523 | $66 |
| Metoprolol | 356 | $13,091 | $37 |
| Ezetimibe | 147 | $12,654 | $86 |
| Livalo | 29 | $12,641 | $436 |
| Pradaxa | 12 | $12,463 | $1,039 |
| Atorvastatin | 489 | $11,998 | $25 |
| Repatha Pushtronex | 15 | $11,706 | $780 |
| Flecainide Acetate | 101 | $10,516 | $104 |
| Chantix | 17 | $8,254 | $486 |
| Ranolazine Er | 18 | $7,606 | $423 |
| Valsartan | 102 | $5,725 | $56 |
| Potassium Chloride | 92 | $5,401 | $59 |
| Diltiazem 24hr Er (Cd) | 68 | $4,263 | $63 |
| Olmesartan Medoxomil | 63 | $3,784 | $60 |
| Carvedilol | 225 | $3,525 | $16 |
| Olmesartan-Hydrochlorothiazide | 18 | $3,082 | $171 |
| Diltiazem 24hr Er | 33 | $2,458 | $74 |
| Warfarin | 121 | $2,382 | $20 |
| Cartia Xt | 44 | $2,357 | $54 |
| Losartan | 163 | $2,287 | $14 |
| Amlodipine Besylate | 226 | $2,181 | $10 |
| Matzim La | 11 | $2,156 | $196 |
| Digoxin | 39 | $2,080 | $53 |
| Clopidogrel | 118 | $2,049 | $17 |
| Lisinopril | 164 | $1,878 | $11 |
| Sotalol | 59 | $1,623 | $28 |
| Verapamil Sr | 19 | $1,540 | $81 |
| Dilt-Xr | 27 | $1,499 | $56 |
| Metoprolol | 116 | $1,497 | $13 |
| Spironolactone | 118 | $1,463 | $12 |
| Furosemide | 168 | $1,389 | $8 |
| Simvastatin | 99 | $1,328 | $13 |
| Benazepril | 89 | $1,257 | $14 |
| Montelukast | 59 | $1,237 | $21 |
| Bisoprolol | 12 | $1,224 | $102 |
| Pindolol | 16 | $1,066 | $67 |
| Verapamil Er | 25 | $1,060 | $42 |
| Hydralazine | 39 | $1,028 | $26 |
| Fenofibrate | 12 | $1,027 | $86 |
| Hydrochlorothiazide | 126 | $998 | $8 |
| Isosorbide Mononitrate Er | 35 | $909 | $26 |
| Pravastatin | 35 | $895 | $26 |
| Amiodarone | 38 | $893 | $23 |
| Bumetanide | 11 | $887 | $81 |
| Metolazone | 15 | $877 | $58 |
| Irbesartan | 16 | $861 | $54 |
| Nitroglycerin | 39 | $774 | $20 |
| Diltiazem | 18 | $673 | $37 |
| Levothyroxine | 22 | $619 | $28 |
| Triamterene-Hydrochlorothiazid | 21 | $516 | $25 |
| Diclofenac | 11 | $382 | $35 |
| Atenolol | 13 | $266 | $20 |
| Jantoven | 13 | $97 | $7 |
2018: 72 drugs
| Opsumit | 90 | $840,591 | $9,340 |
| Adcirca | 76 | $327,749 | $4,312 |
| Adempas | 32 | $315,060 | $9,846 |
| Letairis | 29 | $269,980 | $9,310 |
| Eliquis | 293 | $255,006 | $870 |
| Uptravi | 14 | $214,226 | $15,302 |
| Orenitram Er | 44 | $134,416 | $3,055 |
| Entresto | 79 | $79,586 | $1,007 |
| Xarelto | 85 | $73,295 | $862 |
| Tadalafil | 16 | $62,459 | $3,904 |
| Repatha Sureclick | 36 | $41,688 | $1,158 |
| Brilinta | 42 | $33,825 | $805 |
| Praluent | 17 | $25,324 | $1,490 |
| Ezetimibe | 103 | $22,157 | $215 |
| Pradaxa | 28 | $21,475 | $767 |
| Rosuvastatin | 280 | $19,720 | $70 |
| Bystolic | 64 | $19,241 | $301 |
| Ranexa | 21 | $14,346 | $683 |
| Metoprolol | 289 | $12,378 | $43 |
| Atorvastatin | 458 | $11,439 | $25 |
| Flecainide Acetate | 92 | $9,864 | $107 |
| Livalo | 26 | $8,993 | $346 |
| Propafenone Hcl Er | 13 | $5,750 | $442 |
| Olmesartan Medoxomil | 54 | $4,046 | $75 |
| Prasugrel | 12 | $4,035 | $336 |
| Valsartan | 104 | $3,897 | $37 |
| Omega-3 Acid Ethyl Esters | 27 | $3,617 | $134 |
| Warfarin | 148 | $3,048 | $21 |
| Diltiazem 24hr Er (Cd) | 51 | $3,038 | $60 |
| Potassium Chloride | 83 | $2,679 | $32 |
| Digoxin | 35 | $2,589 | $74 |
| Diltiazem 24hr Er | 44 | $2,527 | $57 |
| Carvedilol | 196 | $2,431 | $12 |
| Metolazone | 25 | $2,413 | $97 |
| Cartia Xt | 61 | $2,280 | $37 |
| Fenofibrate | 17 | $2,034 | $120 |
| Clopidogrel | 125 | $2,018 | $16 |
| Amlodipine Besylate | 187 | $1,925 | $10 |
| Sotalol | 65 | $1,924 | $30 |
| Isosorbide Mononitrate Er | 53 | $1,808 | $34 |
| Pravastatin | 43 | $1,473 | $34 |
| Verapamil Er | 24 | $1,387 | $58 |
| Losartan | 116 | $1,374 | $12 |
| Metoprolol | 136 | $1,356 | $10 |
| Amiodarone | 21 | $1,336 | $64 |
| Propafenone | 11 | $1,297 | $118 |
| Lisinopril | 158 | $1,294 | $8 |
| Furosemide | 177 | $1,196 | $7 |
| Spironolactone | 113 | $1,177 | $10 |
| Simvastatin | 100 | $1,174 | $12 |
| Olmesartan-Hydrochlorothiazide | 15 | $1,094 | $73 |
| Dilt-Xr | 21 | $1,065 | $51 |
| Benazepril | 88 | $1,016 | $12 |
| Nitroglycerin | 33 | $995 | $30 |
| Digox | 14 | $900 | $64 |
| Hydrochlorothiazide | 91 | $835 | $9 |
| Irbesartan | 23 | $804 | $35 |
| Montelukast | 33 | $768 | $23 |
| Fenofibrate | 13 | $676 | $52 |
| Triamterene-Hydrochlorothiazid | 33 | $642 | $19 |
| Hydralazine | 31 | $629 | $20 |
| Ventolin Hfa | 11 | $604 | $55 |
| Valsartan-Hydrochlorothiazide | 11 | $583 | $53 |
| Tamsulosin | 12 | $574 | $48 |
| Bisoprolol | 12 | $509 | $42 |
| Levothyroxine | 18 | $497 | $28 |
| Ramipril | 12 | $216 | $18 |
| Klor-Con M20 | 13 | $209 | $16 |
| Lisinopril-Hydrochlorothiazide | 14 | $192 | $14 |
| Jantoven | 20 | $184 | $9 |
| Pantoprazole | 20 | $178 | $9 |
| Atenolol | 22 | $133 | $6 |
2017: 59 drugs
| Opsumit | 50 | $435,480 | $8,710 |
| Adempas | 43 | $399,904 | $9,300 |
| Adcirca | 102 | $391,880 | $3,842 |
| Letairis | 33 | $319,975 | $9,696 |
| Eliquis | 262 | $170,263 | $650 |
| Xarelto | 117 | $83,860 | $717 |
| Zetia | 48 | $29,745 | $620 |
| Entresto | 46 | $24,604 | $535 |
| Brilinta | 44 | $23,798 | $541 |
| Bystolic | 59 | $21,454 | $364 |
| Orenitram Er | 15 | $19,066 | $1,271 |
| Ranexa | 32 | $17,018 | $532 |
| Rosuvastatin | 167 | $13,041 | $78 |
| Pradaxa | 31 | $13,014 | $420 |
| Metoprolol | 240 | $9,977 | $42 |
| Atorvastatin | 433 | $9,974 | $23 |
| Ezetimibe | 31 | $9,193 | $297 |
| Livalo | 26 | $7,594 | $292 |
| Olmesartan Medoxomil | 37 | $5,632 | $152 |
| Flecainide Acetate | 51 | $5,548 | $109 |
| Diltiazem 24hr Er | 84 | $4,699 | $56 |
| Potassium Chloride | 103 | $4,384 | $43 |
| Coreg Cr | 12 | $3,824 | $319 |
| Valsartan | 89 | $3,528 | $40 |
| Amiodarone | 30 | $3,342 | $111 |
| Warfarin | 139 | $2,851 | $21 |
| Digoxin | 38 | $2,815 | $74 |
| Clopidogrel | 135 | $2,274 | $17 |
| Carvedilol | 194 | $2,062 | $11 |
| Verapamil Er | 28 | $1,953 | $70 |
| Cartia Xt | 60 | $1,950 | $33 |
| Propafenone | 11 | $1,855 | $169 |
| Amlodipine Besylate | 195 | $1,792 | $9 |
| Losartan | 112 | $1,729 | $15 |
| Sotalol | 34 | $1,638 | $48 |
| Ventolin Hfa | 21 | $1,543 | $73 |
| Metolazone | 26 | $1,530 | $59 |
| Digox | 15 | $1,374 | $92 |
| Lisinopril | 180 | $1,339 | $7 |
| Simvastatin | 137 | $1,287 | $9 |
| Metoprolol | 143 | $1,184 | $8 |
| Benazepril | 104 | $1,133 | $11 |
| Pravastatin | 41 | $1,102 | $27 |
| Nitroglycerin | 38 | $1,051 | $28 |
| Isosorbide Mononitrate Er | 30 | $974 | $32 |
| Furosemide | 168 | $967 | $6 |
| Bisoprolol | 19 | $939 | $49 |
| Valsartan-Hydrochlorothiazide | 22 | $822 | $37 |
| Spironolactone | 58 | $710 | $12 |
| Hydrochlorothiazide | 84 | $685 | $8 |
| Irbesartan | 15 | $581 | $39 |
| Ramipril | 14 | $422 | $30 |
| Hydralazine | 39 | $413 | $11 |
| Levothyroxine | 14 | $410 | $29 |
| Dilt-Xr | 15 | $408 | $27 |
| Lovastatin | 11 | $367 | $33 |
| Triamterene-Hydrochlorothiazid | 21 | $311 | $15 |
| Montelukast | 15 | $308 | $21 |
| Atenolol | 27 | $212 | $8 |
2016: 68 drugs
| Adempas | 37 | $306,690 | $8,289 |
| Opsumit | 38 | $298,394 | $7,852 |
| Letairis | 30 | $257,429 | $8,581 |
| Adcirca | 73 | $232,823 | $3,189 |
| Eliquis | 183 | $101,857 | $557 |
| Xarelto | 102 | $76,432 | $749 |
| Zetia | 65 | $36,827 | $567 |
| Crestor | 73 | $35,868 | $491 |
| Ranexa | 59 | $32,012 | $543 |
| Pradaxa | 36 | $21,899 | $608 |
| Bystolic | 58 | $16,686 | $288 |
| Brilinta | 33 | $15,676 | $475 |
| Benicar | 36 | $14,382 | $399 |
| Atorvastatin | 451 | $12,106 | $27 |
| Entresto | 30 | $10,337 | $345 |
| Vytorin | 12 | $9,207 | $767 |
| Metoprolol | 253 | $8,598 | $34 |
| Livalo | 25 | $6,103 | $244 |
| Daliresp | 12 | $5,313 | $443 |
| Valsartan | 61 | $4,539 | $74 |
| Diltiazem 24hr Er | 87 | $4,403 | $51 |
| Rosuvastatin | 39 | $4,364 | $112 |
| Omega-3 Acid Ethyl Esters | 11 | $4,076 | $371 |
| Digoxin | 63 | $4,016 | $64 |
| Flecainide Acetate | 55 | $3,620 | $66 |
| Verapamil Er | 53 | $3,533 | $67 |
| Warfarin | 166 | $2,885 | $17 |
| Potassium Chloride | 98 | $2,790 | $28 |
| Clopidogrel | 122 | $2,397 | $20 |
| Carvedilol | 251 | $2,388 | $10 |
| Pravastatin | 71 | $2,167 | $31 |
| Diltiazem 24hr Cd | 41 | $2,129 | $52 |
| Benazepril | 160 | $2,046 | $13 |
| Cartia Xt | 45 | $1,791 | $40 |
| Amlodipine Besylate | 186 | $1,780 | $10 |
| Metolazone | 14 | $1,621 | $116 |
| Lisinopril | 145 | $1,553 | $11 |
| Isosorbide Mononitrate Er | 51 | $1,541 | $30 |
| Metoprolol | 165 | $1,496 | $9 |
| Sotalol | 56 | $1,394 | $25 |
| Propafenone | 17 | $1,352 | $80 |
| Hydralazine | 46 | $1,323 | $29 |
| Losartan | 80 | $1,310 | $16 |
| Simvastatin | 135 | $1,271 | $9 |
| Irbesartan | 39 | $1,266 | $32 |
| Bisoprolol | 21 | $1,047 | $50 |
| Furosemide | 185 | $1,029 | $6 |
| Spironolactone | 84 | $964 | $11 |
| Pindolol | 13 | $861 | $66 |
| Ramipril | 21 | $773 | $37 |
| Diltiazem Er | 12 | $754 | $63 |
| Amiodarone | 39 | $680 | $17 |
| Proair Hfa | 12 | $655 | $55 |
| Hydrochlorothiazide | 72 | $635 | $9 |
| Valsartan-Hydrochlorothiazide | 28 | $625 | $22 |
| Dilt-Xr | 16 | $608 | $38 |
| Nitrostat | 20 | $594 | $30 |
| Torsemide | 18 | $568 | $32 |
| Fenofibrate | 12 | $527 | $44 |
| Levothyroxine | 20 | $477 | $24 |
| Atenolol | 49 | $420 | $9 |
| Lovastatin | 12 | $338 | $28 |
| Triamterene-Hydrochlorothiazid | 18 | $308 | $17 |
| Montelukast | 21 | $294 | $14 |
| Clonidine | 20 | $217 | $11 |
| Pantoprazole | 16 | $191 | $12 |
| Lisinopril-Hydrochlorothiazide | 21 | $153 | $7 |
| Terazosin | 12 | $97 | $8 |
2015: 68 drugs
| Letairis | 31 | $231,950 | $7,482 |
| Adcirca | 51 | $123,401 | $2,420 |
| Adempas | 15 | $115,167 | $7,678 |
| Opsumit | 12 | $89,433 | $7,453 |
| Xarelto | 82 | $63,930 | $780 |
| Crestor | 123 | $48,303 | $393 |
| Eliquis | 81 | $38,401 | $474 |
| Zetia | 87 | $37,945 | $436 |
| Bystolic | 87 | $21,740 | $250 |
| Pradaxa | 27 | $17,553 | $650 |
| Benicar | 41 | $14,437 | $352 |
| Ranexa | 29 | $13,409 | $462 |
| Metoprolol | 264 | $10,154 | $38 |
| Atorvastatin | 373 | $8,892 | $24 |
| Vytorin | 22 | $7,988 | $363 |
| Multaq | 14 | $7,361 | $526 |
| Coreg Cr | 19 | $6,350 | $334 |
| Effient | 15 | $6,063 | $404 |
| Welchol | 12 | $5,835 | $486 |
| Livalo | 15 | $4,924 | $328 |
| Warfarin | 229 | $4,573 | $20 |
| Brilinta | 14 | $4,185 | $299 |
| Valsartan | 25 | $3,982 | $159 |
| Diltiazem 24hr Cd | 85 | $3,891 | $46 |
| Omega-3 Acid Ethyl Esters | 15 | $3,627 | $242 |
| Diltiazem Er | 54 | $3,419 | $63 |
| Flecainide Acetate | 69 | $3,374 | $49 |
| Digoxin | 62 | $3,081 | $50 |
| Valsartan-Hydrochlorothiazide | 43 | $2,450 | $57 |
| Carvedilol | 252 | $2,432 | $10 |
| Diltiazem 24hr Er | 50 | $2,407 | $48 |
| Potassium Chloride | 81 | $2,397 | $30 |
| Pravastatin | 61 | $2,246 | $37 |
| Benazepril | 208 | $2,211 | $11 |
| Clopidogrel | 132 | $2,042 | $15 |
| Propafenone | 33 | $1,503 | $46 |
| Lisinopril | 177 | $1,443 | $8 |
| Simvastatin | 155 | $1,420 | $9 |
| Amlodipine Besylate | 164 | $1,387 | $8 |
| Isosorbide Mononitrate Er | 65 | $1,224 | $19 |
| Digox | 23 | $1,214 | $53 |
| Furosemide | 181 | $1,205 | $7 |
| Cartia Xt | 35 | $1,141 | $33 |
| Bisoprolol | 22 | $1,087 | $49 |
| Metoprolol | 137 | $1,073 | $8 |
| Verapamil Er | 27 | $1,022 | $38 |
| Losartan | 84 | $913 | $11 |
| Hydrochlorothiazide | 82 | $897 | $11 |
| Ramipril | 12 | $876 | $73 |
| Sotalol | 41 | $846 | $21 |
| Benazepril-Hydrochlorothiazide | 14 | $822 | $59 |
| Spironolactone | 101 | $806 | $8 |
| Hydralazine | 38 | $761 | $20 |
| Irbesartan | 30 | $754 | $25 |
| Proair Hfa | 12 | $622 | $52 |
| Atenolol | 55 | $604 | $11 |
| Toprol Xl | 11 | $587 | $53 |
| Levothyroxine | 26 | $576 | $22 |
| Amiodarone | 52 | $574 | $11 |
| Torsemide | 14 | $513 | $37 |
| Dilt-Xr | 15 | $502 | $33 |
| Triamterene-Hydrochlorothiazid | 35 | $474 | $14 |
| Nitrostat | 22 | $451 | $20 |
| Montelukast | 29 | $436 | $15 |
| Felodipine Er | 11 | $290 | $26 |
| Lovastatin | 15 | $178 | $12 |
| Klor-Con M10 | 12 | $95 | $8 |
| Lisinopril-Hydrochlorothiazide | 16 | $77 | $5 |
2014: 66 drugs
| Letairis | 42 | $298,817 | $7,115 |
| Adcirca | 84 | $160,693 | $1,913 |
| Xarelto | 101 | $51,949 | $514 |
| Zetia | 104 | $38,106 | $366 |
| Crestor | 105 | $35,279 | $336 |
| Pradaxa | 67 | $26,805 | $400 |
| Diovan | 61 | $17,214 | $282 |
| Vytorin | 37 | $14,877 | $402 |
| Bystolic | 92 | $13,723 | $149 |
| Benicar | 41 | $13,625 | $332 |
| Welchol | 25 | $13,133 | $525 |
| Metoprolol | 252 | $12,153 | $48 |
| Atorvastatin | 449 | $11,828 | $26 |
| Ranexa | 14 | $7,435 | $531 |
| Valsartan | 30 | $6,322 | $211 |
| Fenofibrate | 27 | $6,308 | $234 |
| Eliquis | 13 | $6,241 | $480 |
| Niacin Er | 17 | $6,092 | $358 |
| Brilinta | 16 | $5,257 | $329 |
| Digoxin | 78 | $4,758 | $61 |
| Potassium Chloride | 78 | $4,444 | $57 |
| Livalo | 18 | $3,871 | $215 |
| Carvedilol | 300 | $3,785 | $13 |
| Diltiazem 24hr Er | 77 | $3,232 | $42 |
| Simvastatin | 282 | $3,084 | $11 |
| Warfarin | 225 | $3,028 | $13 |
| Diltiazem Er | 75 | $2,970 | $40 |
| Flecainide Acetate | 69 | $2,830 | $41 |
| Clopidogrel | 146 | $2,795 | $19 |
| Abilify | 13 | $2,607 | $201 |
| Bisoprolol | 57 | $2,605 | $46 |
| Benazepril | 222 | $2,514 | $11 |
| Digox | 52 | $2,168 | $42 |
| Pravastatin | 65 | $2,165 | $33 |
| Valsartan-Hydrochlorothiazide | 37 | $1,942 | $52 |
| Lisinopril | 202 | $1,856 | $9 |
| Diltiazem 24hr Cd | 36 | $1,799 | $50 |
| Amlodipine Besylate | 174 | $1,748 | $10 |
| Coumadin | 13 | $1,729 | $133 |
| Isosorbide Mononitrate Er | 69 | $1,570 | $23 |
| Losartan | 100 | $1,443 | $14 |
| Hydralazine | 78 | $1,336 | $17 |
| Amiodarone | 39 | $1,298 | $33 |
| Proair Hfa | 23 | $1,269 | $55 |
| Sotalol | 50 | $1,161 | $23 |
| Furosemide | 130 | $994 | $8 |
| Metolazone | 18 | $947 | $53 |
| Klor-Con M20 | 21 | $925 | $44 |
| Spironolactone | 106 | $914 | $9 |
| Metoprolol | 132 | $858 | $7 |
| Ramipril | 12 | $776 | $65 |
| Benazepril-Hydrochlorothiazide | 11 | $720 | $65 |
| Nifedipine Er | 11 | $692 | $63 |
| Hydrochlorothiazide | 97 | $667 | $7 |
| Cartia Xt | 24 | $627 | $26 |
| Torsemide | 20 | $608 | $30 |
| Atenolol | 47 | $501 | $11 |
| Losartan-Hydrochlorothiazide | 17 | $434 | $26 |
| Levothyroxine | 32 | $399 | $12 |
| Nitrostat | 22 | $340 | $15 |
| Verapamil Er | 13 | $324 | $25 |
| Montelukast | 19 | $300 | $16 |
| Triamterene-Hydrochlorothiazid | 21 | $287 | $14 |
| Lovastatin | 21 | $268 | $13 |
| Lisinopril-Hydrochlorothiazide | 20 | $167 | $8 |
| Clonidine | 15 | $140 | $9 |
2013: 68 drugs
| Letairis | 24 | $159,905 | $6,663 |
| Adcirca | 52 | $87,691 | $1,686 |
| Pradaxa | 119 | $36,935 | $310 |
| Crestor | 114 | $33,167 | $291 |
| Diovan | 109 | $23,451 | $215 |
| Zetia | 75 | $17,825 | $238 |
| Xarelto | 44 | $17,461 | $397 |
| Lovaza | 29 | $11,704 | $404 |
| Metoprolol | 265 | $11,190 | $42 |
| Multaq | 21 | $11,098 | $528 |
| Benicar | 47 | $10,566 | $225 |
| Atorvastatin | 288 | $10,180 | $35 |
| Fenofibrate | 42 | $9,425 | $224 |
| Vytorin | 33 | $9,291 | $282 |
| Niaspan | 34 | $8,977 | $264 |
| Effient | 30 | $8,804 | $293 |
| Propafenone | 11 | $8,507 | $773 |
| Bystolic | 72 | $8,259 | $115 |
| Potassium Chloride | 104 | $7,949 | $76 |
| Welchol | 12 | $7,610 | $634 |
| Clopidogrel | 155 | $7,064 | $46 |
| Brilinta | 23 | $6,855 | $298 |
| Ranexa | 16 | $5,294 | $331 |
| Coreg Cr | 33 | $4,961 | $150 |
| Livalo | 20 | $4,848 | $242 |
| Diltiazem 24hr Cd | 83 | $4,584 | $55 |
| Simvastatin | 361 | $4,574 | $13 |
| Warfarin | 229 | $3,710 | $16 |
| Flecainide Acetate | 62 | $3,663 | $59 |
| Carvedilol | 309 | $3,610 | $12 |
| Diltiazem 24hr Er | 85 | $3,592 | $42 |
| Benazepril | 269 | $3,460 | $13 |
| Matzim La | 29 | $2,707 | $93 |
| Diltiazem Er | 47 | $2,100 | $45 |
| Hydralazine | 90 | $2,053 | $23 |
| Fenofibrate | 16 | $1,983 | $124 |
| Isosorbide Mononitrate Er | 63 | $1,804 | $29 |
| Micardis | 12 | $1,664 | $139 |
| Losartan | 89 | $1,656 | $19 |
| Amlodipine Besylate | 147 | $1,608 | $11 |
| Lisinopril | 188 | $1,578 | $8 |
| Sotalol | 49 | $1,451 | $30 |
| Spironolactone | 148 | $1,371 | $9 |
| Valsartan-Hydrochlorothiazide | 19 | $1,271 | $67 |
| Amiodarone | 68 | $1,260 | $19 |
| Bisoprolol | 23 | $1,223 | $53 |
| Metoprolol | 172 | $1,216 | $7 |
| Pravastatin | 49 | $1,104 | $23 |
| Furosemide | 195 | $1,057 | $5 |
| Digox | 82 | $944 | $12 |
| Fenofibrate | 18 | $912 | $51 |
| Pantoprazole | 25 | $863 | $35 |
| Verapamil Er | 19 | $783 | $41 |
| Benazepril-Hydrochlorothiazide | 17 | $677 | $40 |
| Cartia Xt | 23 | $669 | $29 |
| Omeprazole | 49 | $576 | $12 |
| Hydrochlorothiazide | 63 | $566 | $9 |
| Metolazone | 25 | $531 | $21 |
| Digoxin | 63 | $527 | $8 |
| Nitrostat | 28 | $433 | $15 |
| Mexiletine | 11 | $422 | $38 |
| Lovastatin | 32 | $393 | $12 |
| Montelukast | 15 | $289 | $19 |
| Tamsulosin | 16 | $270 | $17 |
| Atenolol | 18 | $251 | $14 |
| Fosinopril | 14 | $165 | $12 |
| Triamterene-Hydrochlorothiazid | 12 | $102 | $9 |
| Enalapril Maleate | 18 | $93 | $5 |
Money from drug and device companies
$2,182 in 2025
| 2025 | 16 | 52 | None | $2,182 |
| 2024 | 17 | 60 | None | $2,377 |
| 2023 | 20 | 56 | None | $2,220 |
| 2022 | 14 | 57 | None | $3,359 |
| 2021 | 16 | 53 | None | $1,586 |
| 2020 | 13 | 34 | None | $685 |
| 2019 | 24 | 101 | None | $2,292 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Micra | $601 | 10 payments
|
| Edwards Lifesciences | None | $384 | 3 payments
|
| Merck Sharp & Dohme | Winrevair | $243 | 9 payments
|
| Boston Scientific | Watchman Flx | $237 | 4 payments
|
| Abbott Laboratories | Optis | $213 | 3 payments
|
| Pfizer | Vyndaqel | $107 | 5 payments
|
See all 52 published payments
| Boston Scientific | Meals · 2025-12-19 | Watchman Flx | $87 |
| Medtronic | Meals · 2025-12-19 | Symplicity G3 | $12 |
| Medtronic | Meals · 2025-11-13 | Micra | $141 |
| Medtronic | Meals · 2025-11-11 | Micra | $42 |
| Amgen | Meals · 2025-11-05 | Repatha | $21 |
| Medtronic | Meals · 2025-10-30 | Micra | $68 |
| Merck Sharp & Dohme | Meals · 2025-10-28 | Winrevair | $25 |
| Boston Scientific | Meals · 2025-10-27 | Watchman Flx | $52 |
| Edwards Lifesciences | Meals · 2025-10-22 | None | $84 |
| Pfizer | Meals · 2025-10-14 | Eliquis | $20 |
| Medtronic | Meals · 2025-10-10 | Symplicity G3 | $29 |
| United Therapeutics | Meals · 2025-09-30 | Tyvaso | $22 |
| Pfizer | Meals · 2025-09-23 | Vyndaqel | $27 |
| United Therapeutics | Meals · 2025-09-04 | Orenitram | $22 |
| Merck Sharp & Dohme | Meals · 2025-09-02 | Winrevair | $24 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-26 | Eliquis | $26 |
| Medtronic | Meals · 2025-08-21 | Micra | $22 |
| Merck Sharp & Dohme | Meals · 2025-08-19 | Verquvo | $33 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-18 | Wainua | $19 |
| Edwards Lifesciences | Meals · 2025-08-14 | None | $146 |
| Novartis Pharmaceuticals | Meals · 2025-07-31 | Leqvio | $27 |
| Medtronic | Meals · 2025-07-31 | Micra | $56 |
| Merck Sharp & Dohme | Meals · 2025-07-29 | Winrevair | $26 |
| Amgen | Meals · 2025-07-24 | Repatha | $24 |
| Pfizer | Meals · 2025-07-22 | Vyndaqel | $19 |
| Abbott Laboratories | Meals · 2025-07-22 | Cardiomems | $25 |
| Boston Scientific | Meals · 2025-07-21 | Watchman Flx | $47 |
| Medtronic | Meals · 2025-06-23 | Micra | $124 |
| Esperion Therapeutics | Meals · 2025-06-17 | Nexletol | $17 |
| Merck Sharp & Dohme | Meals · 2025-06-16 | Verquvo | $27 |
| United Therapeutics | Meals · 2025-06-04 | Tyvaso | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-03 | Eliquis | $16 |
| Merck Sharp & Dohme | Meals · 2025-05-20 | Winrevair | $30 |
| Abbott Laboratories | Meals · 2025-05-16 | Optis | $161 |
| Pfizer | Meals · 2025-05-13 | Eliquis | $21 |
| Pfizer | Meals · 2025-05-05 | Vyndaqel | $20 |
| Boston Scientific | Meals · 2025-05-01 | Watchman Flx | $52 |
| Actelion Pharmaceuticals US | Meals · 2025-04-29 | Uptravi | $25 |
| Medtronic | Meals · 2025-04-24 | Venaseal | $17 |
| Scpharmaceuticals | Meals · 2025-04-17 | Furoscix | $21 |
| Merck Sharp & Dohme | Meals · 2025-04-01 | Verquvo | $25 |
| Edwards Lifesciences | Meals · 2025-03-13 | None | $154 |
| United Therapeutics | Meals · 2025-03-04 | Orenitram | $21 |
| Novartis Pharmaceuticals | Meals · 2025-02-25 | Leqvio | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-20 | Camzyos | $18 |
| Merck Sharp & Dohme | Meals · 2025-02-18 | Winrevair | $25 |
| Novo Nordisk | Meals · 2025-02-03 | Ozempic | $14 |
| Medtronic | Meals · 2025-01-23 | Micra | $90 |
| Merck Sharp & Dohme | Meals · 2025-01-22 | Verquvo | $27 |
| Philips North America | Meals · 2025-01-21 | Mcot | $30 |
| Abbott Laboratories | Meals · 2025-01-20 | Triclip | $28 |
| Actelion Pharmaceuticals US | Meals · 2025-01-14 | Uptravi | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,377
| Edwards Lifesciences | Mitris Resilia Mitral Valve | $457 | 3 payments
|
| Merck Sharp & Dohme | Winrevair | $292 | 9 payments
|
| Abbott Laboratories | Cardiomems | $291 | 7 payments
|
| Actelion Pharmaceuticals US | Uptravi | $246 | 6 payments
|
| Medtronic | Micra | $206 | 7 payments
|
| Heartflow | Ffrct | $185 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $134 | 3 payments
|
| Novartis Pharmaceuticals | Leqvio | $114 | 5 payments
|
| United Therapeutics | Tyvaso | $94 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $72 | 3 payments
|
| Esperion Therapeutics | Nexletol | $69 | 3 payments
|
| Amgen | Repatha | $53 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $47 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $39 | 2 payments
|
| Boston Scientific | Watchman Flx | $31 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $28 | 1 payment
|
| Pfizer | Vyndaqel | $19 | 1 payment
|
2023: $2,220
| Medtronic | Micra | $735 | 13 payments
|
| Abbott Laboratories | 2nd Gen Centrimag Primary Console | $390 | 6 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $206 | 6 payments
|
| Actelion Pharmaceuticals US | Uptravi | $179 | 5 payments
|
| Edwards Lifesciences | None | $164 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $77 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $74 | 4 payments
|
| Esperion Therapeutics | Nexletol | $51 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $50 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $45 | 2 payments
|
| Boston Scientific | Watchman Access System | $41 | 2 payments
|
| iRhythm Technologies | Zio Xt Patch | $32 | 1 payment
|
| Impulse Dynamics (USA) | Optimizer | $30 | 1 payment
|
| Regeneron Healthcare Solutions | Evkeeza | $27 | 1 payment
|
| United Therapeutics | Orenitram | $25 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $24 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $20 | 1 payment
|
| Amgen | Repatha | $19 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $13 | 1 payment
|
2022: $3,359
| Medtronic | Micra | $2,028 | 22 payments
|
| Abbott Laboratories | Cardiomems | $558 | 8 payments
|
| Esperion Therapeutics | Nexlizet | $174 | 4 payments
|
| Actelion Pharmaceuticals US | Uptravi | $169 | 4 payments
|
| Merck Sharp & Dohme | Verquvo | $167 | 4 payments
|
| Boston Scientific | General - Therapies | $61 | 3 payments
|
| Impulse Dynamics (USA) | Optimizer | $36 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $32 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $31 | 2 payments
|
| United Therapeutics | Orenitram | $25 | 1 payment
|
| Amgen | Repatha | $24 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $24 | 4 payments
|
| iRhythm Technologies | Zio Xt Patch | $16 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $15 | 1 payment
|
2021: $1,586
| Abbott Laboratories | Cardiomems Hf System | $561 | 7 payments
|
| Medtronic | Micra | $199 | 5 payments
|
| Amgen | Repatha | $193 | 5 payments
|
| Amarin Pharma | Vascepa | $122 | 13 payments
|
| United Therapeutics | Orenitram | $112 | 4 payments
|
| Actelion Pharmaceuticals US | Opsumit | $86 | 4 payments
|
| Esperion Therapeutics | Nexletol | $67 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $62 | 3 payments
|
| Preventice Services | Bg Mini Plus | $42 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $38 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $25 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $23 | 2 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $19 | 1 payment
|
| Shockwave Medical | Vascular Lithotripsy | $14 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $12 | 1 payment
|
| Pfizer | Eliquis | $12 | 1 payment
|
2020: $685
| Abbott Laboratories | Fortify Assura, Ellipse Icd | $148 | 4 payments
|
| United Therapeutics | Orenitram | $127 | 6 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $76 | 4 payments
|
| Bayer HealthCare Pharmaceuticals | Adempas | $67 | 5 payments
|
| Amgen | Repatha | $41 | 2 payments
|
| Kowa Pharmaceuticals America | Livalo | $38 | 2 payments
|
| Esperion Therapeutics | Nexletol | $36 | 2 payments
|
| Actelion Pharmaceuticals US | Uptravi | $33 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $32 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $28 | 2 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $23 | 1 payment
|
| Astellas Pharma US | Lexiscan | $21 | 1 payment
|
| Preventice Services | None | $15 | 1 payment
|
2019: $2,292
| Medtronic Vascular | Selectsecure | $388 | 6 payments
|
| Abbott Laboratories | Mitra Clip System | $322 | 8 payments
|
| Novartis Pharmaceuticals | Entresto | $289 | 19 payments
|
| AngioDynamics | None | $142 | 1 payment
|
| Actelion Pharmaceuticals US | Uptravi | $133 | 10 payments
|
| Abiomed | Impella | $126 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $110 | 10 payments
|
| Bayer HealthCare Pharmaceuticals | Adempas | $109 | 9 payments
|
| Kowa Pharmaceuticals America | Livalo | $85 | 4 payments
|
| United Therapeutics | Orenitram | $76 | 4 payments
|
| Sanofi-Aventis U.S. | Praluent | $73 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $59 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $57 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $56 | 3 payments
|
| Astellas Pharma US | Lexiscan | $44 | 2 payments
|
| Gilead Sciences | None | $44 | 2 payments
|
| Regeneron Healthcare Solutions | Praluent | $40 | 3 payments
|
| Pfizer | Eliquis | $35 | 2 payments
|
| iRhythm Technologies | Zio Patch | $25 | 2 payments
|
| Amarin Pharma | Vascepa | $24 | 1 payment
|
| Portola Pharmaceuticals | Andexxa | $15 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $13 | 1 payment
|
| Aegerion Pharmaceuticals | Juxtapid | $13 | 1 payment
|
| Amgen | Repatha | $11 | 1 payment
|
Professional record
- NPI
- 1609873850
- Licence
- CA A83907California A83907: Current · expires 2026-10-31
- Trained
- Stanford University School of Medicine, 1997 · 29 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A839070
- Taxonomy
- Cardiology (207RC0000X); Federal specialty code 207RI0011X (207RI0011X); Federal specialty code 207UN0901X (207UN0901X)
- Mailing address
- 3536 Mendocino Ave, Ste 200, Santa Rosa, CA, 95403
- NPI first listed
- 2005-07-01
- NPI last updated
- 2012-02-07
This is when the NPI record was last certified, not a medical board exam.